Eikonic Therapeutics

Eikonic Therapeutics is a biotechnology company focused on revolutionizing drug discovery through the application of super-resolution microscopy and advanced image analysis. Co-founded by Nobel Laureate Eric Betzig and industry veteran John McHutchison, the company utilizes its proprietary platform to observe protein dynamics and interactions in living cells at unprecedented scales. This 'optical' approach allows Eikonic to identify and target novel protein-protein interactions (PPIs) that were previously considered undruggable. The company's pipeline primarily targets high-unmet-need areas in oncology, immunology, and neurodegeneration. By integrating AI-driven insights with real-time cellular imaging, Eikonic aims to accelerate the development of precision medicines.